#$%^&*AU2018203371B220191121.pdf#####ABSTRACT Compositions and methods for the treatment of depression and psychoses in humans. More particularly, the invention is directed to formulations containing antipsychotic and/or antidepressant medications including a selective 5-HT2A receptor antagonist/inverse agonist and also containing an NMDAR antagonist.